Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ETHZilla Corp Director's Dealing 2024

Mar 12, 2024

33039_dirs_2024-03-12_de26226f-86b8-4839-bf72-0ba47d4c5eef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2024-02-28

Reporting Person: Jordan Blair (Director)

More from ETHZilla Corp

Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 14
Regulatory Filings 2026
Apr 29
Regulatory Filings 2026
Apr 17
Regulatory Filings 2026
Apr 8
Regulatory Filings 2026
Apr 8
Regulatory Filings 2026
Apr 8
Regulatory Filings 2026
Apr 3
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Feb 20
View all filings →